-
Uncategorized1 week ago
Single-Cell Maps Reveal Genome Reorganization in Alzheimer’s Brain Cells
While Alzheimer’s disease is the most common cause of dementia, many of the molecular mechanisms that drive its progression remain poorly understood. While researchers have cataloged...
-
Uncategorized1 week agoSTAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
In a win for peptide proponents and for health secretary Robert F. Kennedy Jr., an advisory panel to the Food and Drug Administration recommended on Thursday...
-
Uncategorized1 week ago
Autism-Like Traits in Mice Improved After Single Rapamycin Dose
Autism-Like Traits in Mice Improved After Single Rapamycin Dose
-
Uncategorized1 week ago
Midlife Brain Aging Linked to Immune Cell Remodeling, Blood-Brain Barrier Decline
Midlife Brain Aging Linked to Immune Cell Remodeling, Blood-Brain Barrier Decline
-
Uncategorized1 week ago
Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump
Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump
-
Uncategorized1 week agoU.S. health officials are investigating a new outbreak of a diarrhea-causing parasite
Federal health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora. The outbreak included 72 people as of Wednesday. Read the rest… Read More
-
Uncategorized1 week agoSTAT+: European regulators take steps to bolster clinical trial transparency
In a boost for greater clinical trial transparency, the European Medicines Agency (EMA) is taking what consumer advocacy groups are calling unexpectedly “rapid action” to ensure...
-
Uncategorized1 week agoSenate health panel delays vote on CDC nominee
WASHINGTON — The Senate’s health panel delayed until next week a vote on Erica Schwartz to run the Centers for Disease Control and Prevention, after postponing...
-
Uncategorized1 week agoLilly, with new data, to seek FDA approval of obesity drug retatrutide
The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug...
-
Uncategorized1 week agoFDA panel confronting peptide controversy
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The FDA is weighing a...
